Navigation Links
Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology

Elucidation of CF502 mechanism of action and the ability to examine this activity in human cells improve the chances that this drug can offer effective treatment for patients."

CF502, which is being developed by Can-Fite, became part of the development pipeline after Can-Fite had signed a prestigious agreement with the NIH, the leading research institute in the US. Under this agreement, titled CRADA, Can-Fite now cooperates with the laboratory of Prof. Jacobson, a worldwide leading scientist in the field of A3 adenosine receptor agonists and antagonists. Can-Fite is currently in negotiations with the NIH for the licensing of the CF502 molecule.

In addition to CF502, Can-Fite's development pipeline also includes two other drugs, CF101 which is being evaluated for rheumatoid arthritis, dry eye syndrome and psoriasis in phase I clinical trials, and CF102 which is intended for the treatment of liver cancer and hepatitis B. The Company's first commercial agreement was signed with the Japanese Seikagaku Corporation during development of CF101, under the terms of which Can-Fite has already received about USD 5 million.

CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange. The Company, which commenced business activity in 2000, was founded by researcher Prof. Pnina Fishman and patent attorney Dr. Ilan Cohn. The Company focuses on the development of molecule-based drugs that inhibit the development of cancer or inflammatory cells. The market for the company's drugs is estimated at billions of dollars.

Contact

Can-Fite BioPharma
Pnina Fishman, Ph.D., +972-3-9241114
Chief Executive Officer
Fax: +972-3-9249378
pnina@canfite.co.il
http://www.canfite.com/


'"/>




Page: 1 2

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
3. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
4. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
5. CuraGen Presents Update on Clinical Development Program for Belinostat
6. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
9. Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
10. Biomira Selects PX-866 as Clinical Development Candidate and Presents Promising Preclinical Data at AACR
11. Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder
Post Your Comments:
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
(Date:3/27/2015)... , March 27, 2015 Concord Medical ... (NYSE: CCM ), a leading specialty hospital ... network of radiotherapy and diagnostic imaging centers in ... signing of a purchase agreement under which Concord ... subsidiary of the Company, agreed to acquire the ...
(Date:3/26/2015)... -- Huntington Memorial Hospital is the first facility in ... replacement (TAVR), a minimally invasive replacement of heart valves. ... replace an aortic valve without a chest incision or ... The procedure is performed by a dedicated Huntington Hospital ... , MD, interventional cardiologist and Robbin Cohen , ...
Breaking Medicine Technology:RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... 2012   Reportlinker.com announces that a new ... catalogue: , Innovations in Wound Care ... Introduction ... the broad range of sizes, shapes, stages, ...
... Global Information, Inc. (GII) is pleased to announce a new ... Competitive Landscape and Market Forecasts to 2017" by GlobalData. ... Insulin Delivery Devices Market is Set to Grow at a ... GlobalData estimated the global insulin delivery devices ...
Cached Medicine Technology:Innovations in Wound Care Devices and Dressings 2Innovations in Wound Care Devices and Dressings 3Innovations in Wound Care Devices and Dressings 4Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 2Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 3Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 4
(Date:3/28/2015)... Andrew Hawley of Vintage Rock Posters Inc., has announced ... Who and the Doors played together at the Singer Bowl ... Hawley, “The Who toured the United States heavily from 1967 ... the most famous Who poster was a poster created to ... August 2, 1968 at the Singer Bowl in Flushing, New ...
(Date:3/28/2015)... Mirada, CA (PRWEB) March 28, 2015 ... ear, nose and throat disorders, are now ... is a common issue which is characterized by the ... Affecting 1 in 5 people, tinnitus is a prevalent ... disorder and while it is non-fatal, tinnitus can impede ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration on ... Center in Chesapeake, Virginia. Each year, ARDX celebrates Women’s ... the Hampton Roads region. The 2015 Women’s History Month ... grow stronger through sharing their stories and learning the strategies ... theme is T-talk where we will share a cup of ...
(Date:3/28/2015)... March 28, 2015 LTW Cyber is ... to collaborate for the purpose of addressing the needs ... will pursue its own opportunities to grow while seeking ... of LTW Cyber. , Ventures in LTW Cyber focus ... complemented by offerings identifying vulnerabilities and analyzing open source. ...
(Date:3/27/2015)... Deer, Alberta (PRWEB) March 27, 2015 In ... until then, prevented her from working, Monica K. arrived at ... in the mending department quiet, defensive and scared. The owners ... Placement & Support Services (EPSS) to offer jobs to ... does take patience and a willingness to begin with the ...
Breaking Medicine News(10 mins):Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3
... National Council on Radiation Protection and Measurement (NCRP) report ... to seven times more radiation each year from medical ... Radiology (ACR), Society for Pediatric Radiology (SPR), Society of ... Tomography and Magnetic Resonance (SCBT-MR) urge Americans, including elected ...
... Americans were exposed to more than seven times as ... case in the early 1980s, according to a new ... National Council on Radiation Protection and Measurements (NCRP) at ... exposure constituted nearly half of the total radiation exposure ...
... between mothers and fathers may help protect children who ... a new study suggests. , Researchers found that supportive ... and attention levels what researchers call effortful control. ... of aggressive behavior and other forms of "acting out" ...
... Calif., March 3 /PRNewswire/ -- ... that it is expanding the states in which ... the country,s largest private provider of emergency neurology ... than 5,500 emergency neurology consultations to date.(Logo: ...
... to second-generation drug-eluting stentNATICK, Mass., March 3 ... today announced the launch of its TAXUS(R) Liberte(R) ... product was approved on January 28 by the ... was granted yesterday by the National Health Insurance ...
... New Leaders Known for Patient Advocacy, , Thoughtful ... Quality Respiratory Care (CQRC), an alliance of leading home ... one half of the 1.5 million Medicare patients who ... of life, today praised President Obama,s selection of Kansas ...
Cached Medicine News:Health News:Self-Referral of Medical Imaging Exams a Primary Factor in Six-Fold Increase to Americans' Radiation Exposure From Scans Since 1980 2Health News:Self-Referral of Medical Imaging Exams a Primary Factor in Six-Fold Increase to Americans' Radiation Exposure From Scans Since 1980 3Health News:Self-Referral of Medical Imaging Exams a Primary Factor in Six-Fold Increase to Americans' Radiation Exposure From Scans Since 1980 4Health News:Self-Referral of Medical Imaging Exams a Primary Factor in Six-Fold Increase to Americans' Radiation Exposure From Scans Since 1980 5Health News:Self-Referral of Medical Imaging Exams a Primary Factor in Six-Fold Increase to Americans' Radiation Exposure From Scans Since 1980 6Health News:Self-Referral of Medical Imaging Exams a Primary Factor in Six-Fold Increase to Americans' Radiation Exposure From Scans Since 1980 7Health News:Medical Radiation Exposure of the U.S. Population Greatly Increased Since the Early 1980s 2Health News:Supportive co-parenting may reduce some child behavior problems 2Health News:Supportive co-parenting may reduce some child behavior problems 3Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in Montana 2Health News:Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System 2Health News:Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System 3Health News:Council for Quality Respiratory Care Applauds President Obama's Appointments of Governor Sebelius, DeParle to Lead Health Care Efforts 2
... TLIF Instruments are designed to facilitate disc ... bone graft during interbody fusion. The TLIF ... easy use during TLIF, for which they ... be used very effectively in PLIF and ...
... has developed a versatile set of ... interbody fusion procedures precise, simple and ... Instrument Set is the ideal complement ... implants and Bacfix Thoracolumbar System. This ...
CD HORIZON SEXTANT Rod Insertion System...
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
Medicine Products: